logo
Select company
Select metric
60.92%Cash to Assets Ratio
VS
Market
94
Sector
79
Industry
70
History
-
$ 12.96Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 250.22M$ 152.43M60.92%
3/31/2025$ 294.21M$ 215.18M73.14%
12/31/2024$ 378.32M$ 300.13M79.33%
9/30/2024$ 387.04M$ 337.54M87.21%
6/30/2024$ 319.38M$ 279.1M87.39%
3/31/2024$ 356.5M$ 325.1M91.19%
12/31/2023$ 413.84M$ 384.26M92.85%
9/30/2023$ 236.99M$ 216.53M91.37%
6/30/2023$ 265.04M$ 249.38M94.09%
3/31/2023$ 144.01M$ 130.08M90.33%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash to Assets stands at 98.04%.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average Cash to Assets has been 90.73%.
  • The median Cash to Assets for PHATHOM PHARMACEUTICALS INC during this period was 93.47%
  • PHATHOM PHARMACEUTICALS INC reached its highest Cash to Assets over the past 5 years at 98.35%.
  • The lowest Cash to Assets recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe 60.92%

PHATHOM PHARMACEUTICALS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
GYRE : GYRE THERAPEUTICS INC 23.91%ANAB : ANAPTYSBIO INC 13.21%NAGE : NIAGEN BIOSCIENCE INC 66.07%CRMD : CORMEDIX INC 63.07%TBPH : THERAVANCE BIOPHARMA INC 66.37%ZYME : ZYMEWORKS INC 24.06%URGN : UROGEN PHARMA LTD 45.03%ZVRA : ZEVRA THERAPEUTICS INC 18.62%XNCR : XENCOR INC 5.09%KURA : KURA ONCOLOGY INC 12.01%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for PHATHOM PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 226.36M ] / Assets [ $ 230.89M ]
(=) Cash to Assets [ 98.04% ]

PHAT - Cash to Assets Ratio, Last 5 years

60.92%

Minimum

Jun 30, 2025

98.35%

Maximum

Sep 30, 2021

90.73%

Average

93.47%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%